Cargando…
Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
Mixed cryoglobulinemia (MC) is an autoimmune/B-cell lymphoproliferative disorder associated with Hepatitis C Virus (HCV) infection, manifesting as a systemic vasculitis. In the last decade, antiviral treatment (AT) with pegylated interferon (Peg-IFN) plus ribavirin (RBV) was considered the first the...
Autores principales: | Urraro, Teresa, Gragnani, Laura, Piluso, Alessia, Fabbrizzi, Alessio, Monti, Monica, Fognani, Elisa, Boldrini, Barbara, Ranieri, Jessica, Zignego, Anna Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359800/ https://www.ncbi.nlm.nih.gov/pubmed/25815218 http://dx.doi.org/10.1155/2015/816424 |
Ejemplares similares
-
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia
por: Fognani, Elisa, et al.
Publicado: (2013) -
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
por: Stasi, Cristina, et al.
Publicado: (2014) -
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
por: Zignego, Anna Linda, et al.
Publicado: (2012) -
149 HCV AND lymphoma: Genetic and epigenetic factors
por: Zignego, AL, et al.
Publicado: (2014) -
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022)